|
Legal
| Date |
Type |
Title |
|
Nov 17, 2005 |
Article,DrugNews |
Research: Actemra Monotherapy Significantly Slows Down Damage to Joints in Patients with Early Aggressive RA
Roche announced the results of the first Phase III study in rheumatoid arthritis (RA) conducted by Chugai in Japan, which were presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Diego, USA. These data conclude for the first time that Actemra in monotherapy shows superiority to conventional disease modifying anti-rheumatic drugs (DMARDs) in inhibiting radiographic progression of joint destruction. |
|
Apr 01, 2004 |
DrugNews |
Emerging Rheumatoid Arthritis Therapeutics: Eight New Potential Products
Study identifies eight new potential products to enter the market in the next five years With the worldwide prevalence of rheumatoid arthritis (RA) estimated at more than 20 million people in 2004. |
|
Sep 24, 2003 |
DrugNews |
FDA Requests Additional Data on Arthritis and Pain Drug, Lumiracoxib
Novartis Pharmaceuticals
Corporation announced today that the US Food and Drug Administration (FDA) has requested the submission of the final report of the ongoing TARGET study as well as additional clinical data for lumiracoxib* for the indications of osteoarthritis and acute pain before marketing approval in the US may be granted. |
|
Feb 26, 2003 |
Article |
Can't stand the pain? Your genes may be to blame
A tiny variation in a single gene may help explain why some people can withstand pain -- or other physical or emotional stress -- better than others, researchers from the University of Michigan and the National Institutes of Health report.
|
|
Dec 02, 2002 |
Article |
Work and Arthritis: Legal Rights
Federal laws have made the playing field more level for people with arthritis and other disabling conditions who wish to remain employed. The Americans with Disabilities Act of 1990, and its "ancestor" the Rehabilitation Act of 1973, give important protection to workers in the private sector and the federal government. The Family and Medical Leave Act also provides relief to workers faced with lengthy absences because of illness. Your state also may have laws that protect people with disabilities from discrimination.
|
|
Oct 25, 2002 |
Article |
Distorted Fear of Addiction to Prescription Drugs Seen as Major Barrier to Effective Pain Treatment
In a paper recently published by the Open Society Institute a leading neurologist specializing in pain and palliative care said that many of the more than 50 million people in the United States living with chronic pain forgo effective treatment with prescription medication due to misperceptions and fears of addiction.
|
|
Jul 12, 2002 |
Article |
Depression in Mothers Caring for Chronically Ill Children Can Make Problems Worse
Children with chronically painful illnesses are frequently depressed, as anyone might expect. The problems for young people facing such diseases as rheumatoid arthritis or cancer are complex, but how their mothers feel about themselves may play an important role in their children's well being.
|
|
|
|
|
